Skip to main content
OpenTrials
Completed

NCT Number: NCT04437732

Apioc Presbyopic Contact Lens

In this study, you will wear an invesetigational contact lens, Apioc-P or Apioc-PT, the way you wear your current contact lenses for approximately one month (no more than 35 days).

Completed

Looking for future studies?

Notify Me

Key information

Age range

40 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Quinn Foster & Associates, Athens, Ohio, United States

Loading trial locations.

About this study

Apioc-P and Apioc-PT is an investigational contact lens, which means it has not been approved by the U.S. Food and Drug Administration (FDA), although the contact lens material, called Definitive 74, is already approved and marketed for contact lenses that are similar to Apioc-P and Apioc-PT. In this study, participants will wear an Apioc-P and Apioc-PT contact lens the way they wear their current contact lenses for approximately one month (no more than 35 days).

Participation in this study will include a minimum of four study visits. The first will last up to 90 minutes, the second will last up to 45 minutes, the third will last up to 45 minutes, and the final visit will be up to 90 minutes. If the lens does not appear to be fitting properly at the second visit, then another lens will be ordered for participants and they will be asked to return for an additional visit for up to 45 minutes. Up to 60 subjects will participate in this study.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • The subject must provide written informed consent.
  • The subject must appear willing and able to adhere to the instructions set forth in this protocol.
  • At least 40 years of age and no more than 70 years of age.
  • ≤ 4.00 D of corneal astigmatism.
  • ≤ 4.00 D of refractive astigmatism.
  • Refractive error range +20.00 DS to -20.00 DS
  • Keratometry readings within 40 to 50D.
  • Clear, healthy corneas with no irregular astigmatism.
  • Normal, healthy conjunctiva in both eyes.
  • Free of active ocular disease. Refractive error and presbyopia are permitted.
  • Be a current or former (within the last 12 months) contact lens wearer.
  • Best-corrected near and distance visual acuity better than or equal to 20/25.

Exclusion criteria

  • Irregular corneal astigmatism.
  • Corneal scarring unless off line-of-site and well healed.
  • Pinguecula, pterygium, or other conjunctival thickness abnormalities that would interfere with soft contact lens wear.
  • Recent use of any ocular pharmaceutical treatments, including daily artificial tears, in the two weeks prior to the examination. Use of artificial tears less than 3 times per week is permitted.
  • Systemic disease that would interfere with contact lens wear.
  • Currently pregnant or lactating (by self-report).
  • History of strabismus or eye movement disorder, including exophoria at near that is 4D or greater than at far, and a receded near point of convergence break that is 6 cm or greater.
  • Active allergies that may inhibit contact lens wear.
  • Upper eyelid margin at or above the superior limbus.
  • History of ocular or lid surgery.

Treatment and study plan

Apioc-P and Apioc-PT Contact Lens Design

Device

Novel soft contact lens design

Primary outcomes

  1. Visual Acuity

    Time frame: 30 days

    LogMAR visual acuity

Secondary outcomes

  1. Comfort

    Time frame: 30 days

    Contact Lens Dry Eye Questionnaire-8, scale range 0 minimum (better outcome) to 38 maximum (worse outcome).

Sponsors and collaborators

Lead sponsor

Lentechs, LLC

Industry

Registry information

Official study title

30 Day Trial Fitting of a New Bifocal Contact Lens

Important dates

Study start
2019
Primary completion
2021
Study completion
2021
First posted
Jun 18, 2020
Registry last updated
Jan 19, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.